Search results
Eli Lilly (LLY) Q4 Earnings Beat, Mounjaro, Zepbound Drive Sales
Zacks via Yahoo Finance· 3 months agoEli Lilly and Company LLY reported fourth-quarter 2023 adjusted earnings per share (“EPS”) of $2.49,...
Eli Lilly (LLY) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 months agoImage source: The Motley Fool. Eli Lilly (NYSE: LLY) Q4 2023 Earnings Call Feb 06, 2024, 10:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Lilly (LLY) Up 7.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 2 months agoA month has gone by since the last earnings report for Eli Lilly (LLY). Shares have added about 7.5%...
Eli Lilly warns against ‘cosmetic’ use of popular diabetes, obesity drugs
The Hill via Yahoo News· 4 months agoDrugmaker Eli Lilly on Thursday warned against using its diabetes and obesity drugs for “cosmetic”...
Eli Lilly (LLY) Q3 Earnings & Sales Top, EPS View Cut, Stock Up
Zacks via Yahoo Finance· 6 months agoEli Lilly (LLY) beats third-quarter estimates for earnings as well as sales. It cut its earnings...
Weight loss drug Zepbound is now available, Eli Lilly says
CNN via Yahoo News· 5 months agoDrug manufacturer Eli Lilly announced Tuesday that its flagship weight loss medication, Zepbound, is...
Ozempic, Mounjaro and hundreds of other drugs become even more expensive in 2024
CNN Business via Yahoo Finance· 2 months agoSome Americans may have to shell out more this year for Ozempic and Mounjaro, two wildly popular...
Eli Lilly and Co (LLY) Reports 28% Revenue Surge in Q4 2023, Forecasts Continued Growth
GuruFocus.com via Yahoo Finance· 3 months agoRevenue Growth: Q4 2023 revenue increased by 28% year-over-year, reaching $9.35 billion. Earnings...
Campbell Soup and Eli Lilly have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – January 10, 2023 – Zacks Equity Research shares Campbell Soup...
Strong obesity medication now available, if you can get it.
USA TODAY via Yahoo News· 6 months agoPeople struggling with obesity now have a second, and possibly a more effective, medication option ‒...
